• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社会经济决定因素与有利风险前列腺癌中主动监测或观察等待的利用和结果有关。

Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer.

机构信息

Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

出版信息

Cancer Med. 2023 Apr;12(8):9868-9878. doi: 10.1002/cam4.5650. Epub 2023 Feb 2.

DOI:10.1002/cam4.5650
PMID:36727535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10166939/
Abstract

BACKGROUND

Active surveillance/watchful waiting (AS/WW) is feasible and effective for favorable-risk prostate cancer (PCa). Understanding socioeconomic determinants of AS/WW may help determine the target population for social support and improve cancer-related survival.

METHODS

The Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database 18 Registries identified 229,428 adult men diagnosed with primary localized PCa (clinical T1-T2c, N0M0) during a median follow-up of 45 months between 2010 and 2016. Socioeconomic determinants included socioeconomic status (SES) tertiles, marital status (unmarried vs married), and residency (urban vs rural). Multivariable logistic regression and Cox models determined the adjusted odds ratios (aOR) for AS/WW utilization, and adjusted hazard ratio (aHR) for cancer-specific survival (CSS) and overall survival (OS). The extent of missing data was evaluated by multiple imputation. Sensitivity analyses were performed in multiple imputation datasets.

RESULTS

Unmarried patients were more likely to receive AS/WW in low-risk group (aOR, 1.20 [95%CI, 1.12-1.28]; p < 0.001) and favorable intermediate-risk group (aOR, 1.41 [95%CI, 1.26-1.59]; p < 0.001) than married patients. Urban patients had 0.77-fold lower likelihood of AS/WW than rural patients in low-risk group (95% CI, 0.68-0.87; p < 0.001), but not in favorable intermediate-risk groups. Among patients undertaking AS/WW, a significantly worse OS was observed among unmarried patients comparing to married group (aHR, 1.98 [95% CI, 1.50-2.60]; p < 0.001), and patients with high SES had better CSS than low group (aHR, 0.08 [95%CI, 0.01-0.69]; p = 0.02). No significant survival difference was found between urban and rural patients.

CONCLUSIONS AND RELEVANCE

Unmarried or urban patients had significantly higher rates of AS/WW. The utilization and efficacy of conservative management were affected by socioeconomic factors, which might serve as a barrier of treatment decision-making and targeted a population in need of social support.

摘要

背景

主动监测/观察等待(AS/WW)对于低危前列腺癌(PCa)是可行且有效的。了解社会经济决定因素可能有助于确定需要社会支持的目标人群,并改善与癌症相关的生存。

方法

监测、流行病学和最终结果前列腺观察等待数据库 18 个登记处确定了 229428 名成年男性,他们在 2010 年至 2016 年期间中位随访 45 个月期间被诊断为原发性局限性 PCa(临床 T1-T2c,N0M0)。社会经济决定因素包括社会经济地位(SES)三分位数、婚姻状况(未婚与已婚)和居住地点(城市与农村)。多变量逻辑回归和 Cox 模型确定了 AS/WW 利用的调整后优势比(aOR),以及癌症特异性生存(CSS)和总生存(OS)的调整后危险比(aHR)。通过多重插补评估缺失数据的程度。在多重插补数据集进行敏感性分析。

结果

与已婚患者相比,低危组(aOR,1.20[95%CI,1.12-1.28];p<0.001)和中危组(aOR,1.41[95%CI,1.26-1.59];p<0.001)中未婚患者更有可能接受 AS/WW。低危组中,城市患者接受 AS/WW 的可能性比农村患者低 0.77 倍(95%CI,0.68-0.87;p<0.001),但在中危组中并非如此。在接受 AS/WW 的患者中,与已婚组相比,未婚患者的 OS 明显更差(aHR,1.98[95%CI,1.50-2.60];p<0.001),而 SES 较高的患者 CSS 好于 SES 较低的患者(aHR,0.08[95%CI,0.01-0.69];p=0.02)。城市和农村患者的生存无显著差异。

结论和相关性

未婚或城市患者接受 AS/WW 的比例明显较高。保守治疗的利用和疗效受到社会经济因素的影响,这可能成为治疗决策的障碍,并针对需要社会支持的人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354c/10166939/189f14e1edb3/CAM4-12-9868-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354c/10166939/c7b873fec3e7/CAM4-12-9868-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354c/10166939/189f14e1edb3/CAM4-12-9868-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354c/10166939/c7b873fec3e7/CAM4-12-9868-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354c/10166939/189f14e1edb3/CAM4-12-9868-g001.jpg

相似文献

1
Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer.社会经济决定因素与有利风险前列腺癌中主动监测或观察等待的利用和结果有关。
Cancer Med. 2023 Apr;12(8):9868-9878. doi: 10.1002/cam4.5650. Epub 2023 Feb 2.
2
United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015.2010 年至 2015 年,美国不同社会经济地位患者主动监测或观察等待的趋势。
Prostate Cancer Prostatic Dis. 2020 Mar;23(1):179-183. doi: 10.1038/s41391-019-0175-9. Epub 2019 Oct 7.
3
The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.《新监测、流行病学和最终结果前列腺观察等待数据库:机遇与局限》。
Eur Urol. 2020 Sep;78(3):335-344. doi: 10.1016/j.eururo.2020.01.009. Epub 2020 Jan 21.
4
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database.美国年轻男性与老年男性低危前列腺癌的保守治疗:来自新型国家数据库的趋势和结果。
Cancer. 2019 Oct 1;125(19):3338-3346. doi: 10.1002/cncr.32332. Epub 2019 Jun 28.
5
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.量化低危前列腺癌患者从主动监测向密切观察转变的情况。
Eur Urol. 2017 Oct;72(4):534-541. doi: 10.1016/j.eururo.2016.10.031. Epub 2016 Nov 2.
6
The comparison of survival between active surveillance or watchful waiting and focal laser ablation in patients with low-risk prostate cancer.主动监测或观察等待与低危前列腺癌患者的局灶性激光消融治疗的生存比较。
Asian J Androl. 2022 Sep-Oct;24(5):494-499. doi: 10.4103/aja2021113.
7
Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.主动监测与观察等待对局限性前列腺癌的比较:一种辅助决策的模型。
Eur Urol. 2017 Dec;72(6):899-907. doi: 10.1016/j.eururo.2017.07.018. Epub 2017 Aug 23.
8
Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.选择观察等待作为局限性前列腺癌初始治疗方法的男性患者的时间趋势及特征:来自CaPSURE的结果
J Urol. 2003 Nov;170(5):1804-7. doi: 10.1097/01.ju.0000091641.34674.11.
9
Overtreatment and Underutilization of Watchful Waiting in Men With Limited Life Expectancy: An Analysis of the Michigan Urological Surgery Improvement Collaborative Registry.预期寿命有限的男性中过度治疗和观察等待利用不足:密歇根泌尿外科手术改善协作登记处的分析。
Urology. 2020 Nov;145:190-196. doi: 10.1016/j.urology.2020.07.047. Epub 2020 Aug 7.
10
Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.主动监测在中危前列腺癌患者中的应用及早期死亡率结果。
Cancer. 2019 Sep 15;125(18):3164-3171. doi: 10.1002/cncr.32202. Epub 2019 May 31.

引用本文的文献

1
Key Determinants Influencing Treatment Decision-Making for and Adherence to Active Surveillance for Prostate Cancer: A Systematic Review.影响前列腺癌积极监测治疗决策和依从性的关键决定因素:一项系统综述。
J Pers Med. 2025 Jul 15;15(7):315. doi: 10.3390/jpm15070315.

本文引用的文献

1
Evaluating the state of the art in missing data imputation for clinical data.评估临床数据缺失值插补的最新技术状态。
Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab489.
2
Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database.PSA 在 10-20ng/mL 之间的中危前列腺癌的主动监测:人群水平数据库的病理结果分析。
Prostate Cancer Prostatic Dis. 2022 Apr;25(4):690-693. doi: 10.1038/s41391-021-00448-8. Epub 2021 Sep 10.
3
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.
患有糖尿病的人感染 COVID-19 疾病的风险和风险因素:苏格兰全人群的队列研究。
Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93. doi: 10.1016/S2213-8587(20)30405-8. Epub 2020 Dec 23.
4
Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer.前列腺癌主动监测患者活检依从性对结局的影响。
J Urol. 2020 Nov;204(5):934-940. doi: 10.1097/JU.0000000000001091. Epub 2020 Apr 24.
5
The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.《新监测、流行病学和最终结果前列腺观察等待数据库:机遇与局限》。
Eur Urol. 2020 Sep;78(3):335-344. doi: 10.1016/j.eururo.2020.01.009. Epub 2020 Jan 21.
6
Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.局部前列腺癌主动监测、手术、近距离放疗或外照射放疗联合或不联合雄激素剥夺治疗 5 年的患者报告结局。
JAMA. 2020 Jan 14;323(2):149-163. doi: 10.1001/jama.2019.20675.
7
Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.1 级前列腺癌的主动监测:来自大型前瞻性队列的长期结果。
Eur Urol. 2020 Jun;77(6):675-682. doi: 10.1016/j.eururo.2019.12.017. Epub 2020 Jan 7.
8
Active Surveillance for Black Men with Low-Risk Prostate Cancer in the United States.美国对低风险前列腺癌黑人男性的主动监测
N Engl J Med. 2019 Dec 26;381(26):2581-2582. doi: 10.1056/NEJMc1912868.
9
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.根据接受的治疗,来自ProtecT随机对照试验的局限性前列腺癌男性患者的十年死亡率、疾病进展及治疗相关副作用
Eur Urol. 2020 Mar;77(3):320-330. doi: 10.1016/j.eururo.2019.10.030. Epub 2019 Nov 24.
10
United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015.2010 年至 2015 年,美国不同社会经济地位患者主动监测或观察等待的趋势。
Prostate Cancer Prostatic Dis. 2020 Mar;23(1):179-183. doi: 10.1038/s41391-019-0175-9. Epub 2019 Oct 7.